Abituzumab

Tax included
Abituzumab (DI17E6) is a humanised anti-integrin αV monoclonal antibody (IgG2 type). Abituzumab effectively reduces the phosphorylation of FAK, Akt and ERK. Abituzumab can be used in cancer research, particularly in prostate cancer.
MedChemExpress 
HY-P99183

Data sheet

Size
Multiple sizes
Reactivity
Integrin
Application
Cancer-Kinase/protease
CAS
1105038-73-0